CI

At a glance

ClinicalIndex Comparison Record
N/AUnknown· 120 enrolled
Drug / intervention
Trident Acetabular X3 Insertdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02543437
NCT02543437N/AUnknown

The Effect of Large Diameter Head to Prevent Dislocation, and of 3 rd Generation Highly Crosslinked Polyethylene to Reduce Wear in Computer Assisted Total Hip Arthroplasty.

Stryker Japan K.K.·interventional·Posted Sep 7, 2015·Updated Oct 15, 2018

In Brief

A clinical study evaluating Trident Acetabular X3 Insert for Degenerative Joint Disease. Targeting 120 participants across 4 sites.

Detailed Summary

The purpose of this study is to explore the benefit of X3 polyethlene inserts with larger diameter heads used in the Japanese population. Range of Motion (ROM) and lift-off distance for both 28mm, 32mm and 36mm in patients will be examined intraoperatively by using the Stryker computerized tomography (CT) based Navigation system. Another aspect of this study is to observe wear resistance performance of X3 over historical liner existing highly crosslinked polyethylene.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesJapan
Collaborators--

Timeline

N/AUnknownOverdue
2011201220132014201520162017201820192020202120222023202420252026
First PostedSep 7, 2015
Enrollment StartJul 1, 2010
Primary CompletionDec 1, 2011
Study CompletionJul 1, 2019
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 10.8 years ago

Interventions

Trident Acetabular X3 Insertdevice